Influenza Vaccines: Unmet Needs and Recent Developments

Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Ji Yun, Kim, Woo Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902815/
https://www.ncbi.nlm.nih.gov/pubmed/24475351
http://dx.doi.org/10.3947/ic.2013.45.4.375
_version_ 1782301035298029568
author Noh, Ji Yun
Kim, Woo Joo
author_facet Noh, Ji Yun
Kim, Woo Joo
author_sort Noh, Ji Yun
collection PubMed
description Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described.
format Online
Article
Text
id pubmed-3902815
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-39028152014-01-28 Influenza Vaccines: Unmet Needs and Recent Developments Noh, Ji Yun Kim, Woo Joo Infect Chemother Review Article Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013-12 2013-12-27 /pmc/articles/PMC3902815/ /pubmed/24475351 http://dx.doi.org/10.3947/ic.2013.45.4.375 Text en Copyright © 2013 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Noh, Ji Yun
Kim, Woo Joo
Influenza Vaccines: Unmet Needs and Recent Developments
title Influenza Vaccines: Unmet Needs and Recent Developments
title_full Influenza Vaccines: Unmet Needs and Recent Developments
title_fullStr Influenza Vaccines: Unmet Needs and Recent Developments
title_full_unstemmed Influenza Vaccines: Unmet Needs and Recent Developments
title_short Influenza Vaccines: Unmet Needs and Recent Developments
title_sort influenza vaccines: unmet needs and recent developments
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902815/
https://www.ncbi.nlm.nih.gov/pubmed/24475351
http://dx.doi.org/10.3947/ic.2013.45.4.375
work_keys_str_mv AT nohjiyun influenzavaccinesunmetneedsandrecentdevelopments
AT kimwoojoo influenzavaccinesunmetneedsandrecentdevelopments

Ejemplares similares